Fentigliv 600mg Vaginal Capsule contains Fenticonazole, an antifungal agent used primarily to treat vaginal infections caused by susceptible fungi and yeast, including Candida species and dermatophytes. This medication works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting the integrity of the fungal cell wall and leading to cell death. Fentigliv is indicated for the treatment of vulvovaginal candidiasis, providing effective relief from symptoms such as itching, burning, discharge, and irritation. The 600mg dosage is designed for intravaginal use, typically administered once daily at bedtime for a prescribed duration, usually ranging from one to two weeks depending on the severity of the infection and the healthcare provider’s recommendation. It is important to complete the full course of treatment to ensure eradication of the infection and prevent recurrence. Patients should avoid sexual intercourse during treatment to enhance efficacy and reduce the risk of transmission. Fentigliv is generally well tolerated, though mild local irritation or discomfort may occur. It is contraindicated in individuals with known hypersensitivity to Fenticonazole or any of the capsule’s excipients. Consultation with a healthcare professional is advised before use, especially in pregnant or breastfeeding women.